top of page
Our Blog
See below for an opinion on current matters around the world.
Search


Costs and benefits: how has the Pharmaceutical Benefits Scheme contributed to Australia over the last quarter century?
Brendan Shaw How much value for money does Australia get from the Pharmaceutical Benefits Scheme? Following on from an earlier blog ...
Brendan Shaw
Mar 258 min read
110 views
0 comments


Recognising rebates: the role of pharmaceutical companies in funding UK and Australian pharmaceutical schemes
Brendan Shaw and Vinh Vo The United Kingdom and Australia have a long tradition of mostly friendly rivalry over things like cricket and...
Brendan Shaw
Feb 257 min read
128 views
0 comments


The Best & the Worst? Five Trends for Pharma to Watch in 2025
Brendan Shaw Article published in PharmaBoardroom, 9 January 2025, found at: https://pharmaboardroom.com/articles/the-best-the-worst-five...
Brendan Shaw
Jan 91 min read
6 views
0 comments


Raising the Bar: How the 2024 Access to Medicine Index Shapes the Pharmaceutical Industry’s ESG Agenda
Unjela Kaleem Globally, the pharmaceutical industry has a crucial role, sitting at the nexus of innovation, ethics, and public health. As...
Brendan Shaw
Dec 2, 20244 min read
56 views
0 comments


The Good, the Bad, and the Ugly: Australia’s HTA Review Final Report
Brendan Shaw "The HTA Review Report is farsighted enough to be visionary, while being firmly grounded in the practicalities of the here...
Brendan Shaw
Nov 13, 20247 min read
253 views
0 comments


Is the new price right?: HTA takes a back seat to broader price negotiations
Brendan Shaw I don't always say this but spare a thought for the harried and hapless bureaucrats responsible for managing governments and...
Brendan Shaw
Oct 26, 20247 min read
107 views
0 comments


Christmas Santa or Christmas Scrooge?: England's new medicines pricing regime sends mixed messages
Brendan Shaw “I will honour Christmas in my heart and try to keep it all the year. I will live in the Past, the Present, and the Future....
Brendan Shaw
Dec 7, 20237 min read
67 views
0 comments


Land of the Long Wait Crowd: problems in New Zealand's medicine funding system
Brendan Shaw "It is so important that New Zealanders are able to access new, emerging and effective cancer treatments that are the...
Brendan Shaw
Sep 4, 20239 min read
1,319 views
0 comments


Have health and the PBS come of age as the Intergenerational Report turns 21?
Brendan Shaw Article published in Biopharmadispatch, 28 August 2023, (paywall) which can be found here. #medicines #ageing #economics...
Brendan Shaw
Aug 27, 20231 min read
11 views
0 comments

Pharmaceuticals Take Centre Stage in Australian Election Campaign
Brendan Shaw Article on the 2022 Australian national election campaign published on 25 May in PharmaBoardroom. The article examines the...
Brendan Shaw
May 24, 20221 min read
20 views
0 comments


Australians now understand there is a 'queue' for new health technologies
Podcast interview of Brendan Shaw with Paul Cross from BioPharmaDispatch, 8 December 2021 that can be heard here. The interview discusses...
Brendan Shaw
Dec 8, 20211 min read
33 views
0 comments


NICE methods review, UK Life Sciences Strategy and the life sciences industry: lessons for Australia
Brendan Shaw “We must balance ensuring the NHS gets the best value, delivering improved patient access and promoting innovation. These...
Brendan Shaw
Sep 11, 20216 min read
132 views
0 comments


Fair dinkum or collywobbles? Life sciences and the Australia – UK free trade agreement
Brendan Shaw “Fair dinkum – (adj, Australian informal), true, genuine, authentic” - Aussie Slang Dictionary “Collywobbles – (noun, UK...
Brendan Shaw
Jun 17, 20215 min read
102 views
1 comment


More risk for government this time around in agreement negotiation
Brendan Shaw Article published in BioPharmaDispatch 9 April 2021 on the risks for government and industry in negotiations on a new...
Brendan Shaw
Apr 8, 20211 min read
9 views
0 comments


It's just the vibe: soft skills in the art of government-business relations
Brendan Shaw "It’s just the vibe of the thing.” - Denis Denuto, The Castle “Principle #1: Build strong relationships ahead of time....
Brendan Shaw
Mar 21, 20215 min read
102 views
0 comments


5 Trends for Life Science Companies to Watch in 2021
Brendan Shaw Article published in PharmaBoardroom on 14 January 2021 can be found here: https://pharmaboardroom.com/articles/5-trends-for...
Brendan Shaw
Jan 14, 20211 min read
15 views
0 comments


The next 20-year PBS agenda: government commitments to new medicines spending
Brendan Shaw If it's real and if it sticks, the Australian government’s ‘New Medicines Funding Guarantee’ will be a significant...
Brendan Shaw
Oct 14, 20203 min read
129 views
0 comments


PBS New Medicines Funding Guarantee: echoes of elections past ...
Brendan Shaw Article published in BiopharmaDispatch on 13 October 2020 on the Australian Government's 2020 Budget announcement on funding...
Brendan Shaw
Oct 13, 20201 min read
21 views
0 comments
bottom of page